Business:
Oncology Treatments
Drug notes:
5 add'l products RD oncology
About:
Alterome Therapeutics is focused on developing next-generation, small molecule targeted therapies for precision treatment of cancer. Their approach is centered around identifying and targeting specific alterations within cancer cells, leading to the development of highly selective and potent therapeutic agents. Alterome's pipeline leverages their in-house platform, The Kraken, which uses computational chemistry to design targeted cancer therapies. One of Alterome's key areas of research is the development of inhibitors for KRAS mutations. They developed ALTA-2618, an orally bioavailable, mutant-selective, and covalent allosteric inhibitor of AKT1 E17K. They are also exploring other high-value and validated oncogenic targets.
Staff Accountant San Diego, California|4 days ago